Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Working later in life a lifesaver for some, a drag for others
Health Opinion

Working later in life a lifesaver for some, a drag for others

'It keeps us healthy and gives us an extra reason to get up in the morning’.

Covid helped polarise us
Opinion

Sir Peter Gluckman: Covid helped polarise us

The pandemic's consequences continue to reverberate. 

F&P Healthcare: don’t mention the tariffs!
Markets

F&P Healthcare: don’t mention the tariffs!

Mexican and Chinese plants could face tariffs on exports to the US.

Pattrick Smellie 28 Nov 2024
Record half for F&P Healthcare
Markets

Record half for F&P Healthcare

A strong result boosts dividend, suspends dividend reinvestment scheme.

Pattrick Smellie 28 Nov 2024